Link to record in KAR

Force parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of molecular motor function. Hypertrophic cardiomyopathy (HCM) is the most frequently occurring inherited cardiovascular disease. It is caused by mutations in genes encoding the force-generating machinery of the cardiac sarcomere, including human β-cardiac myosin. We present a detailed characterization of the most debated HCM-causing mutation in human β-cardiac myosin, R403Q. Despite numerous studies, most performed with nonhuman or noncardiac myosin, there is no consensus about the mechanism of action of this mutation on the function of the enzyme. We use recombinant human β-cardiac myosin and new methodologies to characterize in vitro contractility parameters of the R403Q myosin compared to wild type. We extend our studies beyond pure actin filaments to include the interaction of myosin with regulated actin filaments containing tropomyosin and troponin. We find that, with pure actin, the intrinsic force generated by R403Q is ~15% lower than that generated by wild type. The unloaded velocity is, however, ~10% higher for R403Q myosin, resulting in a load-dependent velocity curve that has the characteristics of lower contractility at higher external loads compared to wild type. With regulated actin filaments, there is no increase in the unloaded velocity and the contractility of the R403Q myosin is lower than that of wild type at all loads. Unlike that with pure actin, the actin-activated adenosine triphosphatase activity for R403Q myosin with Ca2+-regulated actin filaments is ~30% lower than that for wild type, predicting a lower unloaded duty ratio of the motor. Overall, the contractility parameters studied fit with a loss of human β-cardiac myosin contractility as a result of the R403Q mutation.

[1]  J. Spudich,et al.  Ensemble Force Changes that Result from Human Cardiac Myosin Mutations and a Small-Molecule Effector , 2015, Cell reports.

[2]  B. Maron,et al.  New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[3]  J. Spudich.  The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy. , 2015, Biochemical Society transactions.

[4]  Matthew S. Lebo,et al.  Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity , 2015, Genetics in Medicine.

[5]  M. Peckham,et al.  Structural Implications of β‐Cardiac Myosin Heavy Chain Mutations in Human Disease , 2014, Anatomical record.

[6]  F. Pagani,et al.  Sarcomere Mutation-Specific Expression Patterns in Human Hypertrophic Cardiomyopathy , 2014, Circulation. Cardiovascular genetics.

[7]  Barry J Maron,et al.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.

[8]  J. Spudich,et al.  Hypertrophic and Dilated Cardiomyopathy: Four Decades of Basic Research on Muscle Lead to Potential Therapeutic Approaches to These Devastating Genetic Diseases , 2014, Biophysical journal.

[9]  J. Spudich,et al.  Effects of Troponin T Cardiomyopathy Mutations on the Calcium Sensitivity of the Regulated Thin Filament and the Actomyosin Cross-Bridge Kinetics of Human β-Cardiac Myosin , 2013, PloS one.

[10]  L. Leinwand,et al.  The Hypertrophic Cardiomyopathy Myosin Mutation R453C Alters ATP Binding and Hydrolysis of Human Cardiac β-Myosin* , 2013, The Journal of Biological Chemistry.

[11]  L. Leinwand,et al.  Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function , 2013, Proceedings of the National Academy of Sciences.

[12]  K. Trybus,et al.  Transgenic Mouse α- and β-Cardiac Myosins Containing the R403Q Mutation Show Isoform-dependent Transient Kinetic Differences* , 2013, The Journal of Biological Chemistry.

[13]  F. T. ten Cate,et al.  Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene Mutations , 2013, Circulation research.

[14]  L. Leinwand,et al.  Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors , 2012, Cellular and Molecular Life Sciences.

[15]  David M. Warshaw,et al.  Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin Motor , 2012, Circulation research.

[16]  Stefan Raunser,et al.  Structure of the Rigor Actin-Tropomyosin-Myosin Complex , 2012, Cell.

[17]  L. Leinwand,et al.  Identification of functional differences between recombinant human α and β cardiac myosin motors , 2012, Cellular and Molecular Life Sciences.

[18]  H. Katus,et al.  Mechanisms of disease: hypertrophic cardiomyopathy , 2012, Nature Reviews Cardiology.

[19]  L. Leinwand,et al.  Cellular mechanisms of cardiomyopathy , 2011, The Journal of cell biology.

[20]  W. Manning,et al.  Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[21]  James A. Spudich,et al.  Functional diversity among a family of human skeletal muscle myosin motors , 2009, Proceedings of the National Academy of Sciences.

[22]  A. Koide,et al.  A peptide tag system for facile purification and single-molecule immobilization. , 2009, Biochemistry.

[23]  M. Yacoub,et al.  The familial hypertrophic cardiomyopathy‐associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils , 2008, The Journal of physiology.

[24]  S. Lowey,et al.  Functional Effects of the Hypertrophic Cardiomyopathy R403Q Mutation Are Different in an α- or β-Myosin Heavy Chain Backbone* , 2008, Journal of Biological Chemistry.

[25]  D. Winkelmann,et al.  Unc45 Activates Hsp90-dependent Folding of the Myosin Motor Domain* , 2008, Journal of Biological Chemistry.

[26]  J. Seidman,et al.  Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. , 2008, American Journal of Physiology. Heart and Circulatory Physiology.

[27]  H. Watkins,et al.  The genetics of hypertrophic cardiomyopathy: Teare redux , 2007, Heart.

[28]  J B Patlak,et al.  Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. , 2007, American journal of physiology. Heart and circulatory physiology.

[29]  Yale E Goldman,et al.  Force generation in single conventional actomyosin complexes under high dynamic load. , 2006, Biophysical journal.

[30]  J. Potter,et al.  Expanding the range of free calcium regulation in biological solutions. , 2005, Analytical biochemistry.

[31]  J. Tardiff.  Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes , 2005, Heart failure reviews.

[32]  T. Kouyama,et al.  Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin. , 2005, European journal of biochemistry.

[33]  R. Cooke,et al.  The force exerted by a muscle cross-bridge depends directly on the strength of the actomyosin bond. , 2004, Biophysical journal.

[34]  Yuan Wang,et al.  Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. , 2004, American journal of physiology. Heart and circulatory physiology.

[35]  H. Flyvbjerg,et al.  Power spectrum analysis for optical tweezers , 2004 .

[36]  D. Winkelmann,et al.  Chaperone-mediated folding and assembly of myosin in striated muscle , 2004, Journal of Cell Science.

[37]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[38]  S. Lowey,et al.  Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. , 2002, Trends in cardiovascular medicine.

[39]  S. Solomon,et al.  Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.

[40]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[41]  K. Trybus,et al.  Biochemical studies of myosin. , 2000, Methods.

[42]  M. Tyska,et al.  Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. , 2000, The Journal of biological chemistry.

[43]  K. Holmes,et al.  The structural basis of muscle contraction. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[44]  J. Seidman,et al.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. , 2000, Circulation research.

[45]  J. Seidman,et al.  Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1999, Circulation research.

[46]  Miriam W. Allersma,et al.  Two-dimensional tracking of ncd motility by back focal plane interferometry. , 1998, Biophysical journal.

[47]  R. Cooke,et al.  Actomyosin interaction in striated muscle. , 1997, Physiological reviews.

[48]  J. Sellers,et al.  The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy , 1997, Journal of Muscle Research & Cell Motility.

[49]  H. Sugi,et al.  Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. , 1997, The Journal of clinical investigation.

[50]  W H Guilford,et al.  Smooth muscle and skeletal muscle myosins produce similar unitary forces and displacements in the laser trap. , 1997, Biophysical journal.

[51]  M. Geeves,et al.  A novel stopped-flow method for measuring the affinity of actin for myosin head fragments using μg quantities of protein , 1996, Journal of Muscle Research & Cell Motility.

[52]  D. Szczesna,et al.  The Role of the Four Ca Binding Sites of Troponin C in the Regulation of Skeletal Muscle Contraction (*) , 1996, The Journal of Biological Chemistry.

[53]  S. Chu,et al.  Quantitative measurements of force and displacement using an optical trap. , 1996, Biophysical journal.

[54]  R. T. Tregear,et al.  Movement and force produced by a single myosin head , 1995, Nature.

[55]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[56]  L. Fananapazir,et al.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.

[57]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[58]  J. Spudich,et al.  Single myosin molecule mechanics: piconewton forces and nanometre steps , 1994, Nature.

[59]  J. Potter,et al.  Isolation, expression, and mutation of a rabbit skeletal muscle cDNA clone for troponin I. The role of the NH2 terminus of fast skeletal muscle troponin I in its biological activity. , 1992, The Journal of biological chemistry.

[60]  J. Potter,et al.  Two genetically expressed troponin T fragments representing alpha and beta isoforms exhibit functional differences. , 1992, The Journal of biological chemistry.

[61]  J. Seidman,et al.  Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. , 1992, The Journal of clinical investigation.

[62]  E. Braunwald.  Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[63]  S. Zoneraich.  Heart Disease: A Textbook of Cardiovascular Medicine , 1992 .

[64]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[65]  M. Way,et al.  Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis , 1989, The Journal of cell biology.

[66]  P. Libby,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[67]  Sivaraj Sivaramakrishnan,et al.  Single-molecule dual-beam optical trap analysis of protein structure and function. , 2010, Methods in enzymology.

[68]  Kenneth C Holmes,et al.  The molecular mechanism of muscle contraction. , 2005, Advances in protein chemistry.

[69]  PhD Jil C. Tardiff MD,et al.  Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes , 2005, Heart Failure Reviews.

[70]  Matthew J. Tyska,et al.  R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level , 2004, Journal of Muscle Research & Cell Motility.

[71]  William,et al.  The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00) , 2004, Biochemistry (Moscow).

[72]  J. Seidman,et al.  Altered Crossbridge Kinetics in the a MHC 403 / 1 Mouse Model of Familial Hypertrophic Cardiomyopathy , 1999 .

[73]  K C Holmes,et al.  Structural mechanism of muscle contraction. , 1999, Annual review of biochemistry.

[74]  M. Geeves,et al.  A novel stopped-flow method for measuring the affinity of actin for myosin head fragments using microgram quantities of protein. , 1996, Journal of muscle research and cell motility.

[75]  J. Spudich,et al.  Assays for actin sliding movement over myosin-coated surfaces. , 1991, Methods in enzymology.

[76]  J. Spudich,et al.  Purification of muscle actin. , 1982, Methods in enzymology.

[77]  L. Smillie.  Preparation and identification of alpha- and beta-tropomyosins. , 1982, Methods in enzymology.

[78]  J. D. Pardee,et al.  [18] Purification of muscle actin , 1982 .

[79]  L. Leinwand,et al.  The cell biology of disease Cellular mechanisms of cardiomyopathy , 2022 .

[80]  E Michael Ostap,et al.  Kinetic and Equilibrium Analysis of the Myosin Atpase , 2022 .

[81]  L. Leinwand,et al.  Identification of functional differences between recombinant human α and β cardiac myosin motors , 2012, Cellular and Molecular Life Sciences.